Continuous subcutaneous foslevodopa/foscarbidopa improves off time in Parkinson's disease; severe adverse events higher in prior DBS group
Patients with Parkinsons disease who had prior brain surgery saw more side effects while using new skin patches
This post hoc analysis of an open-label phase 3 trial evaluated continuous subcutaneous infusion of foslevodopa/foscarbidopa in 244 patients…
A new look at trial data shows skin patches help Parkinsons patients move better and sleep longer. However, those who had brain surgery earl…
Post hoc analysis shows unsuccessful thrombectomy does not worsen outcomes for large ischemic infarcts compared to medical treatment alone
Unsuccessful clot removal did not worsen outcomes for patients with large strokes
In patients with large ischemic infarcts, unsuccessful endovascular thrombectomy did not increase mortality or worsen functional outcomes ve…
For patients with large strokes, a less successful clot removal did not lead to worse survival or function compared to medical treatment alo…
Systematic review finds inflammatory markers elevated in Alzheimer's disease compared to healthy controls across 41 studies
Inflammatory markers linked to Alzheimer's and other dementia types
This systematic review and meta-analysis examined 41 eligible studies involving healthy controls and patients with various dementia subtypes…
A large review found that people with Alzheimer's and other dementias show higher inflammation than healthy people, though more research is …
Noninvasive brain stimulation reduces pain intensity in central poststroke pain with a pooled effect size of -0.64
Noninvasive brain stimulation reduces pain in stroke survivors but does not fix mood
This systematic review and meta-analysis evaluated noninvasive brain stimulation versus sham stimulation in patients with central poststroke…
A review of 430 patients found noninvasive brain stimulation lowers pain in central poststroke pain, though it does not improve mood or qual…
Interactive cognitive-motor training improves mobility, gait, and balance in chronic stroke
Interactive training boosts balance and movement for people with chronic stroke
This systematic review and meta-analysis of 1422 people with chronic stroke found that interactive cognitive-motor training significantly im…
A large review found interactive cognitive-motor training significantly improved balance, mobility, and gait speed for people with chronic s…
GBA1 L444P carriers have ninefold higher odds of Parkinson's disease than non-carriers
People with one GBA1 L444P gene change face much higher risk of developing Parkinson's disease compared to those without it
This systematic review and meta-analysis of 33,752 PD patients and 34,101 controls found that heterozygous GBA1 L444P carriers had markedly …
A large review of over sixty-seven thousand people found that carrying one copy of the GBA1 L444P gene change greatly increases the chance o…
Integrative brain care bundles and transdisciplinary training dismantle structural barriers in maternal-child health globally
New training bundles aim to fix fragmented brain care for mothers and babies worldwide
This narrative review examines global healthcare systems and diverse clinical settings regarding transdisciplinary fetal-neonatal neurology …
Experts suggest new training and care bundles could help integrate brain health support for mothers and infants across the globe.
Oral Semaglutide Failed to Slow Clinical Progression in Early Alzheimer's Disease Across Global Phase 3 Trials
Oral semaglutide did not slow Alzheimer's disease progression in early trials
In large phase 3 trials, oral semaglutide showed no benefit over placebo for patients with early Alzheimer's disease. The drug did not impro…
A large trial found that taking oral semaglutide offered no benefit over placebo for people with early Alzheimer's disease.
High-dose ocrelizumab 1200/1800 mg shows no significant difference in disability progression versus 600 mg in MS
High-dose ocrelizumab did not further reduce disability progression in multiple sclerosis patients
This phase 3b randomized controlled trial in 860 and 753 patients with relapsing or primary progressive multiple sclerosis found that high-d…
A large trial found that higher doses of ocrelizumab did not lower the risk of disability progression compared to the standard dose in multi…
Ocrelizumab reduces disability progression risk in primary progressive multiple sclerosis versus placebo
Ocrelizumab reduces disability risk for primary progressive multiple sclerosis patients
This phase 3b trial evaluated intravenous ocrelizumab versus placebo in patients with primary progressive multiple sclerosis. The study foun…
A large trial found ocrelizumab significantly lowers the risk of disability progression in patients with primary progressive multiple sclero…
Prasinezumab showed non-significant delay in motor progression versus placebo in early-stage Parkinson's disease
Early Parkinson's drug trial shows no delay in motor progression
This phase 2b trial evaluated intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable medication. The study f…
A Phase 2b trial of prasinezumab in early Parkinson's disease failed to meet its primary endpoint of delaying motor progression compared to …
Robot-assisted gait training improves walking ability and functional independence in spinal cord injury
Robot training improves walking after spinal cord injury
This systematic review and meta-analysis of 241 participants with spinal cord injury found that robot-assisted gait training led to signific…
Robot-assisted gait training helps people with spinal cord injury walk farther and more independently than standard rehab alone.